PURPOSE: mapping in detecting FALD in adult patients. METHODS: mapping. Patients in the Fontan group underwent the right heart catheter and liver function tests, including those for fibrotic markers. RESULTS: value was significantly correlated with age, γ-glutamyltransferase, model for end-stage liver disease XI score, and albumin-bilirubin score (P = 0.01, 0.01, 0.044, 0.001). However, it demonstrated no correlation with central venous pressure, pulmonary vessel resistance, or fibrotic markers. CONCLUSION: value derived from CMR may be a non-invasive adjunctive and/or screening marker to detect FALD.
No takes yet. Share an insight, caveat, or question.
Shiina et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: